title: Androgenetic Alopecia: An Update of Treatment Options.
abstract: Androgenetic alopecia (AGA) is characterized by a non-scarring progressive miniaturization of the hair follicle in predisposed men and women with a pattern distribution. Although AGA is a very prevalent condition, approved therapeutic options are limited. This article discusses the current treatment alternatives including their efficacy, safety profile, and quality of evidence. Finasteride and minoxidil for male androgenetic alopecia and minoxidil for female androgenetic alopecia still are the therapeutic options with the highest level evidence. The role of antiandrogens for female patients, the importance of adjuvant therapies, as well as new drugs and procedures are also addressed.
authors.affiliation: Department of Dermatology, Universidade de São Paulo, São Paulo, SP, Brazil. yannakfs@gmail.com.|Department of Dermatology, Hospital do Servidor Publico Municipal de São Paulo, São Paulo, SP, Brazil. yannakfs@gmail.com.|, 1364, Oscar Freire Street, São Paulo, SP, 05409-010, Brazil. yannakfs@gmail.com.
authors.forename: Yanna
authors.initials: Y
authors.lastname: Kelly
authors.affiliation: Department of Dermatology, Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil.
authors.forename: Aline
authors.initials: A
authors.lastname: Blanco
authors.affiliation: Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
authors.forename: Antonella
authors.initials: A
authors.lastname: Tosti
mesh_terms: D000505:Alopecia / Q000188:drug therapy*; D000726:Androgen Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D000818:Animals; D005260:Female; D018120:Finasteride / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008914:Minoxidil / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000726:Androgen Antagonists; D018120:Finasteride; D008914:Minoxidil